Medicine & Life Sciences
Non-Hodgkin's Lymphoma
100%
Lymphoma, Large B-Cell, Diffuse
85%
Survival
67%
Stem Cell Transplantation
61%
Progression-Free Survival
55%
Hematopoietic Stem Cell Transplantation
44%
Lymphoma
44%
plerixafor octahydrochloride
43%
Peripheral Blood Stem Cell Transplantation
43%
Hodgkin Disease
43%
Multiple Myeloma
43%
Lymphocyte Count
42%
Transplants
38%
Rituximab
35%
Granulocyte Colony-Stimulating Factor
32%
Stem Cells
32%
B-Cell Lymphoma
30%
Lymphocytes
29%
ibritumomab tiuxetan
29%
Follicular Lymphoma
28%
Hematopoietic Stem Cell Mobilization
27%
Autografts
26%
Drug Therapy
24%
Immunoglobulin Light-chain Amyloidosis
23%
Peripheral Blood Stem Cells
23%
Monocytes
21%
Everolimus
18%
Radioimmunotherapy
18%
B-Lymphocytes
18%
Cyclophosphamide
18%
Therapeutics
17%
Vincristine
17%
Melphalan
17%
Prednisone
16%
Recurrence
16%
Confidence Intervals
15%
Hematopoietic Stem Cells
15%
Doxorubicin
14%
Lenalidomide
14%
Blood Component Removal
13%
epratuzumab
13%
T-Cell Lymphoma
12%
Placebos
10%
Waldenstrom Macroglobulinemia
10%
Acute Myeloid Leukemia
9%
fludarabine
9%
Brentuximab Vedotin
9%
Allogeneic Cells
9%
B-Cell Chronic Lymphocytic Leukemia
9%
Bone Marrow
9%